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Objective: Hematopoietic stem cell transplantation (HCT) is a stressful and rigorous medical procedure
involving signiﬁcant emotional and immune challenges. The endocannabinoid (eCB) signaling system is
involved in regulation of both the immune system and emotional reactivity, yet little is known about its
function during HCT. We investigated the role of the eCB signaling system in a group of HCT recipients.
Methods: A total of 19 HCT recipients were enrolled and provided psychosocial data and blood samples
at three peri-transplant time points: prior to transplant, hospital discharge, and approximately 100 days
post-transplant. Psychosocial factors, inﬂammatory molecules, and the eCBs were determined and
assessed for changes over this period and association with each other.
Results: HCT recipients demonstrated signiﬁcant changes over the peri-transplant period in inﬂamma-
tory molecules and psychosocial functioning, but not in circulating concentrations of the eCBs. Associ-
ations among these variables were most likely to be present pre-transplant and least likely to be present
immediately post-transplant, with depressive symptoms and inﬂammation most signiﬁcantly associated.
The eCB 2-arachidonoylglycerol (2-AG) was signiﬁcantly, positively associated with both interleukin (IL)-
6 and C-reactive protein (CRP) and negatively associated with depressive symptoms.
Conclusions: The eCB signaling system may have alternative sources and regulatory mechanisms in
addition to the immune system. Given the signiﬁcant associations with inﬂammatory molecules and
depressive symptoms in the peri-transplant period, it is important to better understand this system and
its potential implications in the setting of complex and stressful medical procedures such as HCT.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hematopoietic stem cell transplantation (HCT) is an intensive.edu (J.M. Knight).
rt of the Rochester Center for
try, University of Rochester
Inc. This is an open access article umedical procedure used to treat a variety of hematologic malig-
nancies and disorders whereby stem cells are infused into the
recipient to replace a damaged immune system. This infusion fol-
lows complete or near-complete ablation of the recipient's immune
system with chemotherapy and/or radiation. HCT involves signiﬁ-
cant emotional and immune challenges, with the highest level of
psychosocial stress usually occurring during the early post-
transplant phase (ﬁrst 30 days) (McQuellon et al., 1998). This
period of time is also marked by signiﬁcant immune suppression,nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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endocannabinoid (eCB) system is uniquely positioned to play a
signiﬁcant role in the peri-HCT period as it is a modulator of
emotional reactivity and immune and inﬂammatory responses
(Hillard et al., 2012). There are no reports of studies of the eCB
system in the transplant setting.
Multiple psychosocial factors can affect outcomes after HCT
(Hoodin et al., 2006); in particular, pre-transplant depression and
anxiety are associated with worse post-transplant survival
(Andrykowski et al., 1994; Loberiza et al., 2002). Previous studies
demonstrate that pre-transplant depression and anxiety are also
associated with altered immune function during the post-
transplant period (Gregurek et al., 1996; Knight et al., 2014;
McGregor et al., 2013; Pereira et al., 2010; Pulgar et al., 2012),
with pro-inﬂammatory factors increasing in the immediate post-
transplant period before gradually returning to baseline (Wang
et al., 2008, 2014). Further, pro-inﬂammatory pathways can
mediate the relationship between psychosocial stress and poor
outcomes (Knight et al., 2013; Wang et al., 2008, 2014). These data
suggest that the effects of pre-transplant psychosocial pathology
negatively inﬂuence outcomes as a result of promoting a pro-
inﬂammatory milieu.
The two most well-studied eCBs are 2-arachidonoylglycerol (2-
AG) and N-arachidonylethanolamine or anandamide (AEA); both of
these lipids are present in the circulation (Hillard et al., 2012). The
immune system - speciﬁcally macrophages and platelets - is a
signiﬁcant source of eCB synthesis and release in response to en-
dotoxins and cytokines (Varga et al., 1998). In support of these data,
previous studies demonstrate that circulating concentrations of 2-
AG are increased during inﬂammation (Bluher et al., 2006; Cote
et al., 2007; Di Marzo et al., 2009; Weis et al., 2010). Other
known sources include adipose tissue (Matias et al., 2008; Spoto
et al., 2006) and reproductive organs (El-Talatini et al., 2010).
Since the eCBs are lipophilic, it is likely that their concentrations in
the circulation are also affected by overﬂow from tissues with high
eCB contents, including the brain (Caille et al., 2007).
Previous studies of circulating eCB concentrations have
demonstrated signiﬁcant correlations with both depression and
inﬂammation. Concentrations of 2-AG are signiﬁcantly lower in
individuals diagnosed with major depression (Hill et al., 2009,
2008). Other studies demonstrate that circulating concentrations
of 2-AG are increased during pro-inﬂammatory states (Bluher et al.,
2006; Cote et al., 2007; Di Marzo et al., 2009) and are positively
correlated with concentrations of interleukin 6 (IL-6) (Weis et al.,
2010). These data led us to hypothesize that the profound sup-
pression of the immune system that occurs during the process of
HCT results in loss of eCBs in the circulation. We further hypothe-
sized that depression in this population would be associated with
lower circulating 2-AG concentrations as has been seen in other
populations.
In this pilot study, we were able to test these speciﬁc hypothe-
ses: 1) concentrations of the eCBs are altered over time in HCT
recipients; and 2) circulating concentrations of the eCBs are posi-
tively correlated with pro-inﬂammatory molecules and negatively
correlated with depression in the peri-transplant period. We
further explored the association between the eCBs and anxiety as
well as changes in inﬂammatory markers, depression, and anxiety
over time.
2. Methods
2.1. Patients
A total of 19 men and women who underwent HCT at the Uni-
versity of Rochester Medical Center (URMC) betweenMay 2010 andMay 2011 for any reason participated in this study. To be eligible for
the study, participants had to be at least 18 years of age, English
speaking, and able to complete self-report inventories. Exclusion
criteria included conditions preventing meaningful participation in
the research interview, for example, major, uncorrected sensory
impairments, severe communication limitations such as aphasia,
active psychosis, or acute substance intoxication at the time of the
initial interview as assessed by the study PI (JMK). Participants
were recruited through the study PI after being identiﬁed by their
transplant physician at their pre-transplant visit in the URMC
outpatient HCTclinic. Written informed consent was obtained prior
to study participation.
2.2. Procedures
First, participants completed a packet of demographic infor-
mation in addition to the clinical surveys. At the same time, a
30 ml blood sample was drawn by venipuncture of the antecubital
vein or from central venous access, if available, by a trained nurse
or phlebotomist (time point 1, T1). T1 ranged from 1 to 18 days
prior to transplant (median ¼ 7.5), and always preceded pre-
conditioning regimens. Surveys were administered and blood
collected at two additional time points: at the time of hospital
discharge following initial transplant admission (T2) and as close
to day 100 following transplant as possible (T3). T2 collection time
ranged from day 9 to day 17 post-transplant (median ¼ 12.5) and
T3 ranged from day 91 to day 175 post-transplant (median ¼ 104).
Blood specimens were obtained between 0900 h and 1400 h and
were centrifuged for 10 min at 1000  g. The plasma was then
aspirated, divided into aliquots, and stored at 80 C. Plasma
analyses were performed at the Medical College of Wisconsin
(MCW). Both the URMC and MCW Institutional Review Boards
approved these procedures.
2.3. Plasma endocannabinoid extraction and measurement
Concentrations of AEA and 2-AG were determined simulta-
neously in the same plasma sample. Plasma samples (0.5 ml each)
were thawed and made up to 15% ethanol, to which the internal
standards [2H8]-AEA (16.9 pmol) and [2H8]-2-AG (46.5 pmol)
(Cayman Chemicals, Ann Arbor, MI) were added. Samples were
vortexed and centrifuged at 1000  g for 4 min. The supernatant
was loaded onto Bond Elut C18 solid-phase extraction columns
(1ml; Varian Inc, Lake Forest, CA) which had been conditionedwith
1 ml redistilled ethanol and 3 ml of double distilled water (ddH2O).
The remaining pellet was washed with 100 ml of 15% ethanol and
centrifuged again for 3 min. The resulting supernatant was also
loaded onto the C18 column. Columns were washed with 5 ml
ddH2O and eluted with 1 ml of ethyl acetate. The ethyl acetate layer
in the resulting eluate was removed and dried under N2. Lipids in
the residual ddH2O phase were extracted by mixing with an addi-
tional 1 ml of ethyl acetate, which was added to the original ethyl
acetate solution. Once dried, samples were resuspended in 20 ml of
methanol and stored at 80 C. AEA and 2-AG were quantiﬁed
using liquid chromatography-atmospheric pressure chemical
ionization-mass spectrometry (LC-APCI-MS); selective ion moni-
toring was used to quantify the biogenic lipids as described pre-
viously (Hill et al., 2013).
2.4. Quantitative determination of cytokines in human plasma
Cytokines were quantiﬁed in human plasma using Fluorokine
MAP multiplex kits (R&D Systems, Inc., Minneapolis, MN) accord-
ing to the manufacturer's protocol. The Human High Sensitivity
Cytokine Base Kit was used with corresponding Fluorokine MAP
Table 1
Demographic characteristics of sample population.
N ¼ 17
Mean Age 55 (SD 12.5)
Gender
Male 9 (53%)
Female 8 (47%)
Race/Ethnicity
Caucasian 17 (100%)
Marital Status
Married 13 (76%)
Divorced 3 (18%)
Single 1 (6%)
Living Arrangements
Spouse/signiﬁcant other 9 (53%)
Spouse/signiﬁcant other and children 4 (23.5%)
Other 4 (23.5%)
Education (mean years) 14.47 (2.0 SD)
Employment status
Full time 8 (47%)
Retired 3 (18%)
Disability 4 (23%)
Other 2 (12%)
Income
$10,000e$49,999 4 (24%)
$50,000e$99,999 7 (41%)
$100,000 3 (17.5%)
Don't know/No response 3 (17.5%)
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10, IL-12p70, interferon (IFN)-g, tumor necrosis factor (TNF)-a, and
vascular endothelial growth factor (VEGF) protein concentrations in
plasma samples diluted 2-fold. C-reactive protein (CRP) was
detected using the Human Cardiac Base Kit B with Fluorokine MAP
analyte-speciﬁc bead sets for CRP in plasma samples diluted 1000-
fold. Detection and quantitative analysis of each analyte was per-
formed on the Luminex 200 systemwith integrated software (v2.3)
capable of generating a ﬁve parameter logistic curve-ﬁt. Median
Fluorescent Intensity (MFI) was collected by assigning the bead
region for each analyte beingmeasured at the following instrument
settings: Sample Timeout of 100 s, Minimum beads ¼ 50, Sample
size of 50ul, and Doublet Discriminator gates set at 7500 and
15,500.
2.5. Psychosocial factors
The Demographic Questionnaire is a 12-item self-report
questionnaire that contains items concerning demographics, so-
cioeconomic status, and living circumstances.
Center for Epidemiologic Studies Depression Scale e Revised
(CES-D-R) (Gallo and Rabins, 1999): A 20-item self-report ques-
tionnaire mapping items that form the diagnostic criteria for major
depression; scores range from zero to 60, while a threshold score of
16 may be a sign of signiﬁcant depression.
State-Trait Anxiety Inventory (STAI) (Spielberger, 1989): a 40-
item self-report inventory that is widely used and thoroughly
validated to measure anxiety in adults; we assessed the more
general and long-standing “trait anxiety” (STAI-T) using 20
questions.
2.6. Statistics
The cytokine and endocannabinoid measurements were found
to have a wide dynamic range and highly skewed distribution.
Since these ﬁndings complicated and/or invalidated planned ana-
lyses, the biomarker measurements were transformed using a
base-10 logarithmic transformation. Values below the lower limit
of the detection of the biomarkers were replaced by the lower limit
of detection; this is a conservative approach that is unlikely to lead
to overestimation of differences. Biomarkers with over 25% of
values below the limit of detection (IL-1b, IFN-g, IL-12p70) were
excluded from the analysis. The psychological questionnaire scores
were not transformed.
Descriptive statistics (mean ± SD, median and range) were
calculated separately for each of the three time points. The effect of
time was tested separately for each variable by using a generalized
estimating equations (GEE) model with an exchangeable working
correlation structure to account for the repeated measurements
within each subject. An ANOVA-like hypothesis of no change over
time versus any patterns of change was tested. Within each time-
point, Pearson's correlation analysis was also used to examine the
cross-sectional relationship between the eCBs and the psychosocial
factors and inﬂammatory molecules.
3. Results
Demographic data for study participants are presented in
Table 1. Nineteen subjects were enrolled, with 17 providing base-
line demographic data. Subjects had a mean age of 55 (SD 12.5),
were entirely Caucasian (100%), and the majority were married
(76%). Less than half of the participants were employed full time
(47%). Their diagnoses included acute myelogenous leukemia (5),
lymphoma (4), and multiple myeloma (10). Fourteen patients
received autologous, and 5 received allogeneic (4 sibling,1matchedunrelated donor) transplants; all received peripheral blood stem
cells and all but two patients received inpatient transplants.3.1. Changes over time of biomarkers and psychosocial factors
The means and standard deviations of the biomarkers and
psychosocial measurements at each time point T1-T3 (before
transplant, at the time of hospital discharge, and 100 days following
transplant) are reported in Table 2, which also illustrates the di-
rection of change over time for each variable. Among the bio-
markers evaluated, TNF-a, IL-6, IL-10, CRP, and VEGF signiﬁcantly
varied among the three time points, with T2 being a signiﬁcant
inﬂection point for most inﬂammatory molecules. The pattern of
change for these signiﬁcant variables, except VEGF and TNF-a, was
to increase from T1 to T2 and decrease again at T3; VEGF was
signiﬁcantly decreased at T2 compared to T1 or T3 and TNF-a did
not decline at T3. Circulating eCB concentrations were not signiﬁ-
cantly different among these three time points.
Depressive symptoms (CES-D) and anxiety (STAI-T) changed
signiﬁcantly over time (Table 2). Anxiety was highest preceding
transplant (T1) while depressive symptoms (CES-D) peaked at
hospital discharge (T2). Four participants (26.7%) reported signiﬁ-
cant depressive symptoms (CES-D  16; (Cohen et al., 2006)) at T1;
50% reported such symptoms at T2 and 0% at T3. There was greatest
study attrition at T3; this appeared to be a more prevalent pattern
among those endorsing signiﬁcant depressive symptoms at T2.
Clinically meaningful cut-points for the STAI-T have not been
adequately demarcated in the literature.3.2. The eCBs and their correlation with psychosocial factors and
inﬂammatory molecules
Correlations between the eCBs and the pro-inﬂammatory me-
diators were examined individually at the three time points. Pear-
son correlation analyses demonstrated a signiﬁcant positive
association between 2-AG concentrations and IL-6 and CRP at T1
(IL-6, r ¼ 0.54, p ¼ 0.02; CRP, r ¼ 0.64, p < 0.01) and T3 (IL-6,
r¼ 0.64, p¼ 0.01; CRP, r ¼ 0.59, p¼ 0.03), but not at T2 (Fig. 1). The
Table 2
Summary statistics for biomarkers and psychosocial factors across time points. A GEE model was used separately for each variable to test for the effect of time.
Biomarkers Time 1a N ¼ 18
Mean (SD)
Median (minemax)
Time 2a N ¼ 14
Mean (SD)
Median (minemax)
Time 3a N ¼ 14
Mean (SD)
Median (minemax)
p-valueb
TNF-a (pg/mL) 9.0 (2.3)
8.8 (5.2e13.6)
13.9 (6.3)
10.0 (7.6e23.0)
13.9 (13.0)
9.1 (4.6e57.0)
<0.01
IL-6 (pg/mL) 3.7 (3.9)
2.1 (1.0e14.8)
9.5 (7.3)
8.5 (1.9e28.9)
4.0 (4.5)
2.8 (1.0e18.2)
<0.0001
IL-8 (pg/mL) 24.6 (35.1)
11.9 (5.4e134.4)
14.7 (14.5)
9.1 (3.8e51.4)
19.3 (16.9)
13.3 (2.6e62.6)
0.15
IL-10 (pg/mL) 1.5 (1.7)
1.0 (0.5e7.4)
11.3 (13.9)
2.4 (0.5e33.8)
1.3 (0.9)
1.2 (0.5e4.0)
<0.0001
CRP (mg/mL) 11.5 (11.7)
8.1 (0.1e38.1)
66.7 (38.7)
62.7 (6.5e105.0)
9.1 (9.9)
4.3 (0.2e33.1)
<0.001
VEGF (pg/mL) 64.3 (31.5)
61.9 (15.7e141.4)
51.4 (31.3)
43.3 (12.5e106.6)
89.8 (61.5)
70.4 (23.9e272.0)
<0.0001
2-AG (pmol/mL) 152.5 (208.1)
98.4 (17.8e848.2)
146.6 (169.0)
60.9 (32.1e549.6)
116.1 (156.1)
59.1 (17.6e604.4)
0.69
AEA (pmol/mL) 1.7 (1.0)
1.3 (0.8e5.0)
1.4 (0.5)
1.5 (0.5e2.3)
1.2 (0.6)
0.9 (0.6e3.1)
0.18
Psychosocial factors
Mean (SD)
N ¼ 15 N ¼ 10 N ¼ 9
CES-D 9.3 (9.4)
6 (1e27)
17.8 (13.6)
15 (3e42)
5.6 (5.1)
5 (0e15)
<0.01
STAI-T 39.0 (12.1)
35 (25e61)
33.8 (11.4)
32.5 (22e60)
31.9 (8.7)
29 (20e47)
0.01
a Time 1 ¼ Before transplant (Day 1 e Day 8); Time 2 ¼ Time of hospital discharge (Day þ9 e Day þ17); Time 3 ¼ 100 days post-transplant (Day þ91 e Day þ175).
b GEE-based test for equal mean at all time-points.
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strate a signiﬁcant association between greater depressive symp-
toms and lower 2-AG levels at T1 (r ¼ 0.64, p ¼ 0.01; data not
shown). There were no signiﬁcant associations between 2-AG and
depressive symptoms at T2 or T3. There was no signiﬁcant rela-
tionship between anxiety and the eCBs at any of the time points.
4. Discussion
In the present HCT sample, 2-AG and IL-6 concentrations are
signiﬁcantly, positively correlated in the peri-HCT setting. IL-6 and
2-AG concentrations are signiﬁcantly correlated at T1, prior to
transplantation, and T3, approximately 100 days post transplant.
This correlation is consistent with that seen in individuals under-
going cardiopulmonary bypass, another markedly pro-
inﬂammatory medical condition (Weis et al., 2010). 2-AG is also
signiﬁcantly positively associated with the pro-inﬂammatory
marker CRP in samples taken at T1 and T3, a relationship not pre-
viously reported in the literature. The strength of the correlations
between 2-AG and both IL-6 and CRP are remarkably similar at T1
and T3. However, there was no correlation between 2-AG and
either IL-6 or CRP at T2, when the concentrations of the cytokines
were the highest of the time points sampled. We hypothesize that
the loss of correlation at this time point reﬂects a change in the
source of either the cytokines or 2-AG, resulting in an uncoupling of
this relationship. Consistent with prior literature (Hill et al., 2009),
2-AG demonstrates an inverse relationship with depressive
symptoms in the present HCT sample but only at T1.
As demonstrated in prior studies with HCT patients (Wang et al.,
2008, 2014), pro-inﬂammatory molecules are elevated at T2 in the
present sample despite a decrease in bone marrow-derived he-
matopoiesis and general immune cell production. Indeed, cyto-
kines are produced by many different types of cells; Kupffer cells,
the resident tissuemacrophages of the liver, are able to synthesize a
variety of cytokines (Ramadori and Armbrust, 2001) and peri-
vascular fat locally produces pro-inﬂammatory cytokines (Iantorno
et al., 2014). Pre-transplant chemotherapy regimensmay evoke thislarge cytokine response. Interestingly, however, the circulating
concentration of 2-AGwas unchanged at T2 compared to T1 and T3.
This is in contrast to our hypothesis, which predicted that 2-AG
concentrations would be reduced when the bone marrow-
derived cell numbers are suppressed. This suggests that the
mechanisms regulating circulating concentrations of 2-AG are
complex and include non-inﬂammatory processes. In addition, the
present ﬁndings suggest that the immune system may not be the
primary source of circulating eCBs in the context of HCT, as their
levels remain consistent despite signiﬁcant immune suppression.
As previously identiﬁed in non-transplant populations (Hill
et al., 2008; Hillard et al., 2012), circulating 2-AG concentrations
are negatively correlatedwith depressive symptoms in this study of
HCT recipients. The relationship between 2-AG and depression is
present only at T1. Preclinical data support the hypothesis that 2-
AG reduces depressive symptoms as a result of activation of brain
CB1 receptors (CB1R) (Hillard and Liu, 2014). Since 2-AG concen-
trations did not fall during T2, it is possible that CB1R in the brain
have lost responsivity to 2-AG during this period. This hypothesis is
supported by the down regulation of CB1R in animals exposed to
chronic unpredictable stress (Hill et al., 2005), as would be similar
to the clinical scenario of a stem cell transplant. Alternatively, the
data could suggest that a relatively intact immune system is
necessary for this relationship between depressive symptoms and
2-AG to occur, as evidenced by the absence of this relationship at
assessment time points following transplantation when the host's
immune system is compromised. In sum, additional work is
required to ascertain whether peripheral or central changes - or
both - contribute to this change in relationship between 2-AG and
depression just after transplant.
At T1 and T3, our data demonstrate a signiﬁcant and positive
association between the concentrations of IL-6 and 2-AG. Several
recent studies provide evidence to support the hypothesis that 2-
AG potentiates IL-6 production and suggest that 2-AG could be
up-stream of IL-6. For example, 2-AG containing sera increases LPS-
induced IL-6 expression in a macrophage cell line (Marazzi et al.,
2011). Inhibition of 2-AG catabolism fully blocked diclofenac-
Fig. 1.. Associations between the endocannabinoid 2-arachidonoylglycerol (2-AG) and the inﬂammatory molecules interleukin-6 (IL-6) and C-reactive protein (CRP) pre-transplant,
immediately following transplant, and around Day þ100 post-transplant (T1eT3).
J.M. Knight et al. / Neurobiology of Stress 2 (2015) 44e5048induced increases in gastric concentrations of IL-6, an effect that
required the CB1 receptor (Kinsey et al., 2011). Activation of CB1R in
human adipocyte cultures produces a delayed increase in IL-6
protein release (Gonzalez-Muniesa et al., 2010). Finally, CB2 re-
ceptor deﬁciency results in reduced IL-6 production and mortality
in polymicrobial sepsis (Csoka et al., 2009).
2-AG and its primary receptors, CB1 and CB2, exert complex
effects on the immune system. Both anti-inﬂammatory and pro-
inﬂammatory effects have been reported, depending upon the
cell type and the state of underlying inﬂammation. For example,
loss of CB2 receptors on T cells results in higher T cell entry into the
brain and greater cytokine concentrations in a mouse model of
multiple sclerosis (Maresz et al., 2007). Inhibition of 2-AG catabo-
lism reduces LPS-induced increases in brain cytokine production;
an effect that is attenuated by CB1 receptor blockade (Kerr et al.,
2013). On the other hand, CB2 receptor deﬁciency leads to
reduced neuroinﬂammation in a mouse model of Alzheimer's
Disease (Schm€ole et al., 2015). As described above, data that 2-AG
can increase release of IL-6 are consistent with the ﬁndings ofthis study. However, the results of this study are purely correlative
and do not shed light on potential causative relationships between
2-AG and IL-6 or CRP.
It is noteworthy that during the time of greatest psychosocial
distress (immediately following transplant) and immune suppres-
sion, the relationships among the eCB system and emotion
response and immune function becomes uncoupled. Given the
preclinical data of stress buffering effects of the eCBs (Hillard and
Liu, 2014), it is possible that the dysregulated neuroimmune-2-
AG relationship renders HCT recipients more vulnerable to psy-
chosomatically mediated disease processes during the immediate
peri-HCT time period. The potential for the eCB system to buffer
against psychosocially mediated inﬂammation is important given
the contribution of inﬂammation to adverse medical outcomes
among HCT recipients, including early mortality, graft-versus-host
disease, graft rejection, infection, and disease relapse (Cavet et al.,
1999; Keen et al., 2004; Knight et al., 2013; Nagler et al., 1995;
Schots et al., 1998).
This dysregulation may also contribute to the previously
J.M. Knight et al. / Neurobiology of Stress 2 (2015) 44e50 49observed increased rates of psychopathology among HCT recipients
in the immediate post-transplant time period due to a lack of eCB
buffering of emotional reactivity. Since the eCB effect on depression
was lost without a reduction in 2-AG at T2, this suggests that the
CB1R in the brainmay have lost responsivity during this period. The
present ﬁndings provide a basis for further evaluation in rodent
models to clarify the speciﬁc neuroimmune and behavioral impli-
cations of our preliminary ﬁndings. It is worthwhile to continue
investigation of the interplay of these pathways as the eCB system
may hold promise as a possible therapeutic target in this and other
medically vulnerable populations.
The major limitations of the present study are the small and
heterogeneous sample, thus these data are exploratory. Due to the
sample size limitation, we were unable to control for possibly
confounding medical and demographic variables. Despite these
limitations, the present results are consistent with previous
research involving patterns of change in psychosocial and inﬂam-
matory molecules, suggesting that the present data on circulating
eCBse a biomarker not previously investigated in the HCT settinge
may indeed be generalizable to other HCT populations. Future
studies with HCT patients investigating the eCB system should aim
to recruit larger samples of more homogeneous diseases to control
for possible patient and disease confounders such as preparative
regimens, transplant type, disease and disease status, and other
contributors to inﬂammatory status including body mass index
(BMI), medications, and smoking. Despite its inherent limitations,
the current data provide information suggestive for future study
regarding the role of the eCB signaling system in the peri-HCT
period.
5. Conclusions
2-AG is signiﬁcantly, positively associated with both IL-6 and
CRP in HCT recipients. However, this relationship is lost immedi-
ately post-transplant at the time of greatest immunosuppression.
The fact that these correlations are not consistent suggests that
multiple mechanisms regulate circulating 2-AG concentrations. 2-
AG is negatively correlated with depressive symptoms in HCT re-
cipients, as has been demonstrated in other populations. Further
work is needed to understand the etiology and regulatory path-
ways involved in eCB signaling in the immediate post-transplant
period to elucidate potential roles for risk prognostication, stress
buffering, and therapeutic targets.
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